Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Beter onderscheid tussen 2 bewegingsstoornissen door AI
mei 2025 | Bewegingsstoornissen